Adtalem Global Education (NYSE:CVSA) Issues FY 2027 Earnings Guidance

Adtalem Global Education (NYSE:CVSA) issued an update on its FY 2027 earnings guidance on Thursday morning. The company provided earnings per share guidance of 8.900-9.150 for the period, compared to the consensus earnings per share estimate of 8.880. The company issued revenue guidance of $2.1 billion-$2.1 billion, compared to the consensus revenue estimate of $2.1 billion.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on CVSA shares. Truist Financial boosted their price objective on shares of Adtalem Global Education from $130.00 to $140.00 and gave the stock a “buy” rating in a report on Monday, May 11th. Wall Street Zen cut shares of Adtalem Global Education from a “buy” rating to a “hold” rating in a research report on Saturday, July 25th. Barrington Research reissued an “outperform” rating and issued a $170.00 price target on shares of Adtalem Global Education in a research note on Monday, June 8th. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of Adtalem Global Education in a research report on Friday, May 22nd. Two research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $155.00.

Adtalem Global Education Stock Down 3.0%

Shares of CVSA traded down $3.81 during trading hours on Thursday, reaching $125.10. 547,627 shares of the company traded hands, compared to its average volume of 369,634. Adtalem Global Education has a 12 month low of $86.97 and a 12 month high of $156.26. The company has a debt-to-equity ratio of 0.36, a current ratio of 0.70 and a quick ratio of 0.70. The firm has a fifty day moving average price of $124.15. The stock has a market cap of $4.26 billion, a P/E ratio of 19.49, a price-to-earnings-growth ratio of 0.98 and a beta of 0.62.

Adtalem Global Education (NYSE:CVSA) last issued its quarterly earnings data on Thursday, August 6th. The company reported $2.09 EPS for the quarter, topping the consensus estimate of $1.90 by $0.19. The business had revenue of $501.38 million during the quarter. Adtalem Global Education had a net margin of 12.26% and a return on equity of 20.19%. Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS. On average, analysts expect that Adtalem Global Education will post 8.04 EPS for the current year.

Insider Transactions at Adtalem Global Education

In other news, CFO Robert J. Phelan sold 10,000 shares of the business’s stock in a transaction on Friday, May 8th. The shares were sold at an average price of $126.21, for a total transaction of $1,262,100.00. Following the sale, the chief financial officer owned 55,806 shares in the company, valued at approximately $7,043,275.26. The trade was a 15.20% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Douglas G. Beck sold 9,615 shares of the company’s stock in a transaction dated Friday, May 8th. The stock was sold at an average price of $127.03, for a total transaction of $1,221,393.45. Following the completion of the sale, the senior vice president directly owned 38,159 shares in the company, valued at $4,847,337.77. This represents a 20.13% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 53,183 shares of company stock worth $6,914,570. Corporate insiders own 2.50% of the company’s stock.

Adtalem Global Education Company Profile

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.